Billiontoone, INC. (BLLN) — SEC Filings
Latest SEC filings for Billiontoone, INC.. Recent 10-Q filing on Dec 10, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.
View Billiontoone, INC. on SEC EDGAR
Overview
Billiontoone, INC. (BLLN) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Dec 10, 2025: BillionToOne, Inc. (BLLN) reported a significant increase in revenue and a return to net income for the nine months ended September 30, 2025. Revenue surged to $209.059 million, a substantial increase from $107.505 million in the same period of 2024, representing a 94.47% growth. The company achieve
Sentiment Summary
Across 5 filings, the sentiment breakdown is: 1 bullish, 2 neutral, 2 mixed. The dominant filing sentiment for Billiontoone, INC. is neutral.
Filing Type Overview
Billiontoone, INC. (BLLN) has filed 1 10-Q, 2 8-K, 1 S-1/A, 1 S-1 with the SEC between Oct 2025 to Dec 2025.
Recent Filings (5)
-
BillionToOne Swings to Profit on Near-Doubled Revenue
— 10-Q · Dec 10, 2025 Risk: medium
BillionToOne, Inc. (BLLN) reported a significant increase in revenue and a return to net income for the nine months ended September 30, 2025. Revenue surged to -
BillionToOne, Inc. Files 8-K on Financials and Personnel Changes
— 8-K · Dec 9, 2025 Risk: medium
BillionToOne, Inc. filed an 8-K on December 9, 2025, reporting on its results of operations and financial condition. The filing also covers the departure of dir -
BillionToOne, Inc. Files 8-K with Corporate Updates
— 8-K · Nov 10, 2025 Risk: low
BillionToOne, Inc. filed an 8-K on November 10, 2025, reporting events that occurred on November 7, 2025. The filing indicates amendments to its Articles of Inc -
BillionToOne IPO Targets $265M ARR, Nears Profitability
— S-1/A · Oct 17, 2025 Risk: high
BillionToOne, Inc. (BLLN) is launching its initial public offering of 3,846,000 shares of Class A common stock, priced between $49.00 and $55.00 per share. The -
BillionToOne Files S-1, Targeting Nasdaq Amidst Rapid Revenue Growth
— S-1 · Oct 7, 2025 Risk: high
BillionToOne, Inc. (BLLN) is filing an S-1 for its initial public offering, aiming to list on the Nasdaq Global Select Market. The company, a precision diagnost
Risk Profile
Risk Assessment: Of BLLN's 5 recent filings, 2 were flagged as high-risk, 2 as medium-risk, and 1 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
Key financial metrics from Billiontoone, INC.'s most recent 10-Q filing (Dec 10, 2025):
- Revenue: $209.059M
- Net Income: $1.477M
- EPS: $0.03
- Cash Position: $195.152M
- Operating Margin: 2.72%
- Total Assets: $327.521M
- Total Debt: $55.446M
Key Executives
- Oguzhan Atay
- David Tsao
- Nicholas B. Harley
- Dave Peinsipp
Industry Context
BillionToOne, Inc. operates in the biotechnology or healthcare sector, likely focused on diagnostics or therapeutics. This industry is characterized by high R&D investment, long development cycles, and significant regulatory oversight from bodies like the FDA. Success hinges on innovation, clinical trial outcomes, and effective commercialization strategies in a competitive landscape with both established players and emerging startups.
Top Tags
Precision Diagnostics (3) · Prenatal Screening (3) · Oncology (3) · Biotechnology (3) · IPO (2) · Genetic Testing (2) · Revenue Growth (1) · Profitability (1) · Medical Devices (1) · financial-condition (1)
Key Numbers
- Revenue: $209.059M — Increased from $107.505 million in 2024, a 94.47% growth for the nine months ended September 30, 2025
- Net income: $1.477M — Swung from a net loss of $30.093 million in 2024 for the nine months ended September 30, 2025
- Gross profit (Q3 2025): $58.416M — Increased from $20.215 million in Q3 2024, a 189.97% growth
- Gross profit (YTD 2025): $139.854M — Increased from $55.196 million in YTD 2024, a 153.39% growth
- Cash and cash equivalents: $195.152M — As of September 30, 2025, up from $191.477 million at December 31, 2024
- Diluted EPS (Q3 2025): $0.10 — Improved from $(1.47) in Q3 2024
- Diluted EPS (YTD 2025): $0.03 — Improved from $(2.99) in YTD 2024
- Accumulated deficit: $280.724M — Improved from $(282.201) million at December 31, 2024
- Annualized Revenue Run-Rate (ARR): $265M — Q2 2025 revenue, indicating strong current performance.
- Year-over-Year Revenue Growth: 84% — Q2 2025 compared to Q2 2024, highlighting rapid expansion.
- Last Twelve Months (LTM) Revenue: $209M — As of June 30, 2025, demonstrating significant scale.
- CAGR (2021-2024): 167% — Compound Annual Growth Rate, showing sustained high growth.
- Gross Profit Margin: 65% — H1 2025, a 14 percentage point YOY increase, indicating improved efficiency.
- LTM Tests Accessioned: 508K — As of June 30, 2025, reflecting substantial test volume.
- Total Tests Accessioned: 1M — Since launch, a key operational milestone.
Frequently Asked Questions
What are the latest SEC filings for Billiontoone, INC. (BLLN)?
Billiontoone, INC. has 5 recent SEC filings from Oct 2025 to Dec 2025, including 2 8-K, 1 10-Q, 1 S-1/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of BLLN filings?
Across 5 filings, the sentiment breakdown is: 1 bullish, 2 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find Billiontoone, INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Billiontoone, INC. (BLLN) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Billiontoone, INC.?
Key financial highlights from Billiontoone, INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for BLLN?
The investment thesis for BLLN includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Billiontoone, INC.?
Key executives identified across Billiontoone, INC.'s filings include Oguzhan Atay, David Tsao, Nicholas B. Harley, Dave Peinsipp.
What are the main risk factors for Billiontoone, INC. stock?
Of BLLN's 5 assessed filings, 2 were flagged high-risk, 2 medium-risk, and 1 low-risk.
What are recent predictions and forward guidance from Billiontoone, INC.?
Forward guidance and predictions for Billiontoone, INC. are extracted from SEC filings as they are enriched.